| Schedule of basic and diluted net loss per share |
| Schedule of basic and diluted net loss per share |
|
|
|
|
|
|
|
|
| |
|
For the
year ended
December 31, |
|
| (SEK in thousands) |
|
2025 |
|
|
2024 |
|
| Loss attributable to shareholders |
|
|
(1,721,676 |
) |
|
|
(967,611 |
) |
| Weighted average number of common shares for basic and diluted loss per share |
|
|
43,483,470 |
|
|
|
40,666,082 |
|
| Basic and diluted net loss per share |
|
|
(39.59 |
) |
|
|
(23.79 |
) |
|
| Schedule of antidilutive shares |
| Schedule of antidilutive shares |
|
|
|
|
|
|
|
|
| |
|
For the
year ended
December 31, |
|
| |
|
2025 |
|
|
2024 |
|
| Employee share options |
|
|
1,419,355 |
|
|
|
1,153,020 |
|
| Series A preference shares |
|
|
20,762,302 |
|
|
|
20,762,302 |
|
| Series B preference shares |
|
|
24,173,854 |
|
|
|
24,173,854 |
|
| Series C preference shares |
|
|
23,438,522 |
|
|
|
15,135,490 |
|
| Convertible debenture |
|
|
- |
|
|
|
- |
|
| Employee share purchase warrants |
|
|
16,351,965 |
|
|
|
9,470,134 |
|
| Non-employee share purchase warrants |
|
|
6,854,065 |
|
|
|
6,854,065 |
|
| Total antidilutive shares |
|
|
93,000,063 |
|
|
|
77,548,865 |
|
|